Professor Hilary Calvert has received the Lifetime Achievement Award in the 2009 Excellence in Oncology Awards from the British Oncological Association sponsored by pfizer. Prof Calvert was involved in the development of several oncology drugs in his distinguished career, including carboplatin for ovarian cancer , pemetrexed for Mesothelioma and parp inhibitors. Here he talks about the award and future projects.